|Country of manufacture||India|
Strength : 1mg,3mg,4mg
POMALYST, in combination with dexamethasone, is indicated for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last therapy
Dose: 4 mg PO qDay on days 1-21 of repeated 28-day cycles until disease progression, give in combination with low-dose dexamethasone.
Pomalyst should be taken on doctor prescription.
K M Healthcare is supplier of Pomalidomide.
Generic of Pomalidomide available by Natco.